Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model
2021-08-05 18:00
Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea for Domestic Distribution Rights in Korea for Lamisil®, Lescol® XL and Tegretol®
2021-08-03 21:00
111, Inc. Enters into Strategic Cooperation Agreement with Zelgen to Develop a New Management Platform for Liver Cancer Patients in China
2021-08-03 20:00
TCM Lianhua Qingwen shows stable in vitro antiviral effect on the Delta variant: Expert
2021-08-03 15:27
Bionomics Announces Plans to Conduct U.S. Initial Public Offering
2021-08-02 18:00
LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic
2021-08-02 11:11
Appendix 4C - Q4 FY21 Quarterly Cash Flow Report
2021-07-30 21:05
China Jo-Jo Drugstores Completes Redomiciliation Merger
2021-07-30 21:00
I-Mab Announces IND Approval by FDA to Initiate Phase 1 Study for Protollin for the Treatment of Alzheimer's Disease
2021-07-30 20:00
I-Mab Announces Authorization of a Renewed Stock Repurchase Program by the Company up to US$40 Million
2021-07-29 20:00
HanAll Biopharma Reports Second Quarter 2021 Results
2021-07-29 18:44
Daewoong Pharmaceutical Announces Camostat Achieving 50% Faster Recovery Time for Mild COVID-19 Patients Over Age of 50 in Topline Results from Phase 2B Clinical Trial
2021-07-29 18:00
Clarity commences Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial
2021-07-28 21:08
I-Mab Announces IND Acceptance for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China
2021-07-28 19:15
Kintor Pharmaceutical Announces Dosing of First Batch of Subjects in Phase I Clinical Trial of GT20029 in China
2021-07-28 13:47
I-Mab Announces Preliminary Proposal for Potential Dual Listing on the STAR Market of the Shanghai Stock Exchange
2021-07-27 20:35
PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference
2021-07-26 20:00
HBM Presents Phase I Data on Next-Generation Anti-CTLA-4 Antibody at ESMO Congress 2021
2021-07-26 19:11
Kazia Calls for Increased Focus on Brain Cancer Research this GBM Awareness Day
2021-07-21 22:00
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy
2021-07-20 20:00
1
82
83
84
85
86
147